ASPG and Thrombocytopenia: No differences were observed for grade 3/4 thrombocytopenia with CCRT-VIPD (52.4%) in comparison to 21.9% with CHOP-like, 25.8% with asparaginase and 40.0% with other anti-MDR agent’s regimens, p = 0.100.